How to File a Medicare Part D Formulary Exception (2026)

Direct answer: can you get a drug covered that's off your plan's list?

Yes, you can request a formulary exception if your Medicare Part D plan will not cover a drug you need. Your prescriber submits a written statement of medical necessity, and the plan must decide within 72 hours for a standard request or 24 hours if delaying could harm your health. If approved, the drug is covered for the rest of the 2026 plan year.

What a Part D Formulary Exception Actually Asks For

Medicare Part D plans publish a formulary, the specific list of covered drugs, and every formulary sorts medications into cost-sharing tiers with rules like prior authorization, step therapy, or quantity limits attached to some of them. A formulary exception is a formal request asking the plan to bend one of those rules for a specific enrollee. CMS requires every Part D sponsor in 2026, standalone prescription drug plans and Medicare Advantage drug plans (MA-PD) alike, to offer this exception process whether you pair Medicare Part A and Medicare Part B (together, Original Medicare) with a standalone plan or get drug coverage bundled into a Medicare Advantage plan.

Three distinct exception types exist under the 2026 rules: formulary exceptions, tiering exceptions, and utilization management exceptions, compared in the table above. Medigap policies, unlike Part D plans, include no drug benefit at all, so the exception process only applies once you carry Part D coverage through Original Medicare or a Medicare Advantage plan.

How to File a Part D Formulary Exception in 2026

Filing a formulary exception starts with your prescriber, not with paperwork you complete alone. CMS built the process around clinical judgment, so the six steps below apply whether you are requesting a formulary exception, a tiering exception, or a utilization management exception in 2026.

• Confirm the drug is off-formulary or restricted by checking your plan's 2026 formulary online or calling member services.
• Ask your prescriber to submit a written supporting statement explaining why covered alternatives would be ineffective or harmful.
• Submit the coverage determination request using your plan's form or the CMS Model Coverage Determination Request Form.
• Request an expedited review if your prescriber confirms that waiting 72 hours could seriously harm your health.
• Track the decision deadline: 72 hours standard or 24 hours expedited from when the plan receives the supporting statement.
• Appeal within 60 days if denied, starting with a Level 1 redetermination filed directly with your plan.

Standard vs. Expedited Timelines in 2026

Standard exception requests carry a 72-hour decision deadline in 2026, measured from the moment your plan receives your prescriber's supporting statement, not from the date you first called your plan. Expedited requests carry a tighter 24-hour deadline and apply when your prescriber confirms that waiting for the standard timeline could seriously jeopardize your life, health, or ability to regain maximum function.

Federal rules also protect you if your prescriber never sends a statement: the plan's clock starts automatically 14 calendar days after your request, even without supporting paperwork, though a statement dramatically improves your odds of approval. A missed deadline on the plan's side counts as an automatic denial in 2026, which forwards your case to the independent review entity within 24 hours without any action needed from you.

If Your Exception Request Is Denied: the 2026 Appeals Ladder

Denied exception requests move through five appeal levels in 2026. Level 1 is a redetermination by your own plan, decided within 7 days standard or 72 hours expedited, filed within 60 days of the denial notice. Level 2 sends the case to an independent review entity (IRE) that Medicare, not your plan, contracts with, which decides within 30 days standard or 72 hours expedited.

Level 3 requires an administrative law judge (ALJ) hearing, available only when at least $200 remains in dispute in 2026, up from $190 in 2025 per the Federal Register's annual adjustment. Level 4 is a review by the Medicare Appeals Council, and Level 5 is federal district court review, available when at least $1,960 remains in dispute in 2026.

What It Costs Without an Approved Exception in 2026

Paying full retail price for a non-formulary brand-name drug in 2026 can run $300 to over $1,500 a month depending on the medication, since none of that spending counts toward your deductible or the $2,100 Part D out-of-pocket cap for 2026. An approved exception moves the drug onto your formulary at a defined copay or coinsurance tier instead, and every dollar you pay under that tier counts toward the 2026 cap, after which covered Part D drugs cost $0 for the rest of the year.

Tiering exceptions carry their own cost math: moving a drug from a $47 non-preferred brand copay to a $10 preferred brand copay in 2026, for example, still counts every dollar toward the annual cap, while paying the non-preferred price the whole year does the same math more slowly and more expensively.

Alternatives While You Wait or If the Exception Is Denied

Extra Help, the federal Low-Income Subsidy, remains open for enrollees below 150% of the 2026 Federal Poverty Level (about $23,940 for an individual) and eliminates most cost-sharing regardless of tier, sidestepping the exception fight entirely for eligible beneficiaries. State Pharmaceutical Assistance Programs (SPAPs) in states like Massachusetts, Pennsylvania, and New Jersey provide a second layer of help for specific drug categories.

Manufacturer patient assistance programs, 340B-affiliated pharmacies, and the Medicare Prescription Payment Plan that spreads your 2026 out-of-pocket costs into monthly installments can all reduce the immediate financial pressure while an exception request is pending. Switching Part D plans is also an option: the 2026 Annual Enrollment Period runs October 15 through December 7, 2026, letting you move to a plan whose formulary already covers your drug for coverage starting January 1, 2027, if your current plan keeps denying the exception.

Beneficiaries who are not yet Medicare-eligible face a similar process on ACA-compliant marketplace plans, which must run an internal appeal for excluded drugs under the essential health benefit for prescription coverage and cannot deny an exception based on a preexisting condition.

What is a Medicare Part D formulary exception?

A formulary exception is a formal request asking your Medicare Part D plan to cover a drug that is not on its 2026 drug list, or to waive a plan rule like prior authorization, step therapy, or a quantity limit. Your prescriber submits a written statement explaining why formulary alternatives would not work for your condition. The plan must decide within 72 hours for standard requests or 24 hours for expedited requests in 2026.

How long does Medicare have to decide a formulary exception request?

Standard formulary exception requests must be decided within 72 hours in 2026, and expedited requests within 24 hours, both measured from when the plan receives your prescriber's supporting statement of medical necessity. If no statement arrives, the clock starts automatically 14 calendar days after your request. Missing the deadline counts as an automatic denial that forwards your case to independent review within 24 hours.

Can a pharmacist file a formulary exception for me?

No, a pharmacist generally cannot file the exception request itself, though a pharmacist who cannot fill your prescription as written must give you a notice explaining how to start the process. The supporting statement of medical necessity must come from your prescriber, since the plan needs a clinician's judgment to evaluate whether formulary alternatives would be ineffective or harmful for your specific condition.

What happens if my Part D formulary exception is denied?

You have 60 days to file a Level 1 redetermination with your own plan, decided within 7 days standard or 72 hours expedited in 2026. If the plan upholds the denial, your case automatically moves to an independent review entity for Level 2, then to an administrative law judge for Level 3 if at least $200 remains in dispute in 2026, and potentially federal court beyond that.

Is a tiering exception the same as a formulary exception?

No. A formulary exception adds a drug that is completely off your plan's 2026 drug list, while a tiering exception keeps an already-covered drug but lowers its cost-sharing to a cheaper tier. Tiering exceptions cannot move a drug off the specialty tier under CMS rules, and both exception types use the same 72-hour standard and 24-hour expedited decision deadlines in 2026.

Do Medicare Advantage drug plans (MA-PD) offer the same exception process?

Yes. CMS requires every Part D sponsor in 2026, standalone prescription drug plans and Medicare Advantage drug plans alike, to run the identical formulary exception, tiering exception, and utilization management exception process with the same 72-hour and 24-hour deadlines. The only difference is where you send the request: your MA-PD plan's member services line instead of a standalone Part D plan.

How much does it cost if I don't get an exception approved?

Paying full retail for a non-formulary drug in 2026 can run $300 to over $1,500 a month depending on the medication, and none of that spending counts toward the $2,100 Part D out-of-pocket cap for 2026. Extra Help, manufacturer assistance programs, and 340B pharmacies can lower costs while a request is pending, and switching plans during the 2026 Annual Enrollment Period is another option.

Can I switch Part D plans instead of filing an exception?

Yes, if you can wait for a new plan year. The 2026 Annual Enrollment Period runs October 15 through December 7, 2026, letting you choose a plan whose formulary already covers your drug for coverage starting January 1, 2027. If you need the drug covered sooner, filing a formulary exception with your current plan remains the faster path in 2026.